MedQuist hires acquisitions-focused SVP

Ex-Misys exec to focus on 'all aspects of inorganic growth'

MedQuist Holdings said Monday it has hired a senior executive to oversee its development of strategic partnerships and acquisitions.

The addition of Matt Jenkins as senior vice president of corporate business development comes shortly after Franklin-based MedQuist's hiring of a former Nortel Networks executive to lead its human resources unit. In a statement, the company said Jenkins' strategic partnerships work will include "all aspects of inorganic growth such as acquisitions, investments and alliances." MedQuist has been an active acquirer this year and last week snapped up a Pittsburgh radiology reporting company.

Jenkins formerly led corporate development at MedQuist competitor Allscripts, where he was involved with the company's 2010 merger with Eclipsys as well as its 2008 merger with Misys Healthcare and other deals. Before his time at Misys — which also was a former home to MedQuist Chairman and CEO Vern Davenport — Jenkins was one of the three founders of Cellective Therapeutics, a biotechnology firm focused on oncology and immune-related diseases that was acquired in 2005 by what is now AstraZeneca.

"Our development of an ecosystem of partners is helping us quickly expand our market access through an increased value proposition to customers and validates the strength of our cloud-based, context-enabled speech and natural language understanding technologies," said Davenport. "Matt's experience and associations within the industry will be instrumental in accelerating the execution of this strategy as we move into 2012 and beyond. He's an excellent addition to our senior leadership team."

Shares of MedQuist (Ticker: MEDH) are up about 5 percent to $8.58 in early trading Monday. They've lost about 30 percent of their value in the past six months.